Potent and Selective Fluoroketone Inhibitors of Group VIA Calcium-Independent Phospholipase A2
Citations Over TimeTop 10% of 2010 papers
Abstract
Group VIA calcium-independent phospholipase A(2) (GVIA iPLA(2)) has recently emerged as a novel pharmaceutical target. We have now explored the structure-activity relationship between fluoroketones and GVIA iPLA(2) inhibition. The presence of a naphthyl group proved to be of paramount importance. 1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one (FKGK18) is the most potent inhibitor of GVIA iPLA(2) (X(I)(50) = 0.0002) ever reported. Being 195 and >455 times more potent for GVIA iPLA(2) than for GIVA cPLA(2) and GV sPLA(2), respectively, makes it a valuable tool to explore the role of GVIA iPLA(2) in cells and in vivo models. 1,1,1,2,2,3,3-Heptafluoro-8-(naphthalene-2-yl)octan-4-one inhibited GVIA iPLA(2) with a X(I)(50) value of 0.001 while inhibiting the other intracellular GIVA cPLA(2) and GV sPLA(2) at least 90 times less potently. Hexa- and octafluoro ketones were also found to be potent inhibitors of GVIA iPLA(2); however, they are not selective.
Related Papers
- → A novel type of phospholipase A2 inhibitor, thielocin A1.BETA., and mechanism of action.(1992)27 cited
- → Phospholipase A2 inactivation of microsomal 17β-hydroxysteroid oxidoreductase: Rates of phospholipid hydrolysis and enzyme inactivation, effects of hydrolysis products and properties of the phospholipase A2-treated enzyme(1980)13 cited
- → Quantification of the interaction between lysolecithin and phospholipase A2(1994)11 cited
- → Enhanced phospholipase A2 activity in rat plasma, liver, and intestinal mucosa following endotoxin treatment: A possible explanation for the protective effect of indomethacin in endotoxic shock(1985)32 cited
- → Phospholipases A1 and A2 of rat liver plasma membranes; mechanism of action(1976)25 cited